Her-2 neu (Cerb-B2) expression in fine needle aspiration samples of breast carcinoma: A pilot study comparing FISH, CISH and immunocytochemistry

BACKGROUND: Breast cancers with Her-2 neu gene amplification are recognized as important markers for aggressive disease and targets which respond to therapy with trastuzumab. Her-2 neu testing on histological sections is routinely performed to select patients who may benefit from anti- Her-2 neu the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapila, Kusum, Al-Awadhi, S, Francis, IM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications Pvt Ltd 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111708/
https://www.ncbi.nlm.nih.gov/pubmed/21713147
http://dx.doi.org/10.4103/0970-9371.80731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111708/
https://www.ncbi.nlm.nih.gov/pubmed/21713147
http://dx.doi.org/10.4103/0970-9371.80731

Ejemplares similares